Early diagnosis and consistent treatment are essential for curing drug-resistant tuberculosis (DR-TB), according to medical experts. Bangladesh, a global leader in the fight against tuberculosis, has achieved a treatment success rate of over 90 percent through the implementation of new, short all-oral treatment regimens like BPaL and BPaLM. Despite these advancements, ignorance, social stigma, and clinical negligence continue to hinder efforts towards a TB-free world.
Prof Dr Dewan Azmal Hussain, a specialist in respiratory medicine, highlighted that although Bangladesh has modern diagnostic facilities and a strong medical infrastructure, the psychological barrier remains a significant challenge. Social stigma often forces patients to hide their symptoms or refuse diagnosis, contributing to the spread of the disease.
Assistant Professor Dr Sharmin Sultana (Setu) of the National Institute of Diseases of the Chest and Hospital (NIDCH) explained that clinical signs of drug resistance include persistent symptoms such as cough, fever, chest pain, or weight loss despite regular medication. She stressed the importance of completing the full course of medication and following the Directly Observed Treatment, Short-course (DOTS) method.
Dr Md Shirajul Islam (Sumon), Senior Medical Officer at icddr,b, NIDCH, noted that drug resistance is largely a'man-made' phenomenon, developing due to incomplete treatment, irregular medication, and the use of low-quality drugs. He emphasized the need for nutritional and mental support for patients, as well as 'cough etiquette' to prevent the spread of the disease.
The experts concluded that while science has provided effective treatments, overcoming negligence and stigma is a collective societal responsibility. Bangladesh's role as a global leader in TB treatment underscores the importance of these efforts.
